NYU Langone Health - Perlmutter Cancer Center — New York, New York

NYU Langone Health - Perlmutter Cancer Center is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Langone Health - Perlmutter Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Nonalcoholic Steatohepatitis.

Sponsors: Tobira Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone Health - Perlmutter Cancer Center?

NYU Langone Health - Perlmutter Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone Health - Perlmutter Cancer Center conducted?

NYU Langone Health - Perlmutter Cancer Center has 1 clinical trials on record. Their work covers Nonalcoholic Steatohepatitis.

Is NYU Langone Health - Perlmutter Cancer Center accredited by Crixeo Health?

NYU Langone Health - Perlmutter Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone Health - Perlmutter Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.